Showing results (211-220 of 226) with videos related to
Sort By:
Pageof 23
Journal of Parkinson'S Disease|January 22, 2024
A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson's DiseaseMilton H Werner, C Warren Olanow, Andrew McGarry, et al.The Lancet. Neurology|December 20, 2018
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging studyRalf Reilmann, Andrew McGarry, Igor D Grachev, et al.Cell Metabolism|October 8, 2013
Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar dietYolanda Jimenez-Gomez, Julie A Mattison, Kevin J Pearson, et al.Mayo Clinic Proceedings. Digital Health|June 12, 2025
Much More Than the Malady: The Promise of a Web-Based Digital Platform Incorporating Self-Report for Research and Clinical Care in Mild Cognitive ImpairmentAndrew McGarry, Oliver Roesler, Jackson Liscombe, et al.Science Advances|November 10, 2021
A brain proteomic signature of incipient Alzheimer's disease in young APOE ε4 carriers identifies novel drug targetsJackson A Roberts, Vijay R Varma, Yang An, et al.Analytical Chemistry|December 3, 2021
Cross-Laboratory Standardization of Preclinical Lipidomics Using Differential Mobility Spectrometry and Multiple Reaction MonitoringMohan Ghorasaini, Yassene Mohammed, Jerzy Adamski, et al.Brain : a Journal of Neurology|April 22, 2026
Machine learning model based on plasma proteomics for the identification of Parkinson's diseaseBoluwatife Adewale, Ruth Chia, Ruin Moaddel, et al.Nature Medicine|August 19, 2025
A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosisRuth Chia, Ruin Moaddel, Justin Y Kwan, et al.Clinical Pharmacology and Therapeutics|July 26, 2024
A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy VolunteersShruti M Raja, Jeffrey T Guptill, Michelle Mack, et al.Brain Sciences|January 8, 2025
Galantamine-Memantine Combination in the Treatment of Parkinson's Disease DementiaEmma D Frost, Swanny X Shi, Vishnu V Byroju, et al.Pageof 23